SOX9 and neoplasm: We observed CC3 and nuclear Sox9 staining to be mutually exclusive (Fig. 5c and Extended Data Fig. 5b) at the border of cell death/neutrophil-rich region, providing direct in vivo evidence that the CSCs were resistant to the most potent tumor-killing therapy in our screen.